Corporate Information

• Kancera’s ROR-inhibitor provides higher specificity than competing products

  10 February 2012

• Kancera file patents for ROR inhibitors against cancer

  3 February 2012

• Kanceras strategy is given attention when global expertise in cancer gathers in Washington DC

  2 February 2012

• iNovacia announces collaboration with Agios Pharmaceuticals

  27 January 2012

• Kancera strengthens its patent portfolio in cancer metabolism

  23 December 2011

• iNovacia, GE Healthcare and scientists at Karolinska Institutet collaborate to advance drug discovery strategies

  8 December 2011

• Further clinical support for ROR1 as a diagnostic tool and therapeutic target

  6 December 2011

• Notice of Extraordinary General Meeting Kancera AB

  25 October 2011

• iNovacia AB has developed active compounds as a step towards  treatment of a serious parasitic disease

  13 October 2011

• Kancera has filed patent for new active substances against cancer

  7 October 2011